Cost-utility analysis of genomic profiling in early breast cancer in Colombia

BACKGROUND: In Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study aimed to identify the cost-utility of Oncotype DX™ (ODX) or Mammaprint™ (MMP) tests to establish the necessity of adjuvant chemotherapy. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Leonardo, Rojas-Reyes, María X., Rosselli, Diego, Ariza, Juan Guillermo, Ruiz-Patiño, Alejandro, Cardona, Andrés F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334609/
https://www.ncbi.nlm.nih.gov/pubmed/37430303
http://dx.doi.org/10.1186/s12962-023-00449-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334609/
https://www.ncbi.nlm.nih.gov/pubmed/37430303
http://dx.doi.org/10.1186/s12962-023-00449-5

Ejemplares similares